Share-based Compensation (Tables)

6 Months Ended

Jun. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Share-based Compensation Expense

The following table summarizes our share-based compensation expense by the affected line on our consolidated statements of operations:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
$ in thousands	2023		2022		2023		2022
Cost of services revenue	$	165	$	428	$	245	$	991
Selling, general and administrative	2,210		10,314		(7,543)		21,189
Research and development	441		836		915		2,380
Total share-based compensation expense	$	2,816	$	11,578	$	(6,383)	$	24,560

The following table summarizes our share-based compensation expense by grant type:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
$ in thousands	2023		2022		2023		2022
Stock options	$	200	$	5,416	$	(12,055)	$	11,976
Restricted stock units	2,515		6,108		5,374		12,530
Employee stock purchase plan	101		—		191		—
Vendor Warrants	—		54		107		54
Total share-based compensation expense	$	2,816	$	11,578	$	(6,383)	$	24,560

Schedule of Stock Option Activity

The following table summarizes the Company’s stock option activity:

$ in thousands, except share and per share data	Number of Shares	Weighted Average Exercise Price ($)		Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value ($)
Outstanding balance as of December 31, 2022	31,203,045	$	3.10	7.62	$	10,725
Exercised	(8,876,564)	0.13
Forfeited	(10,578,223)	6.36
Expired	(121,150)	1.69
Outstanding balance as of June 30, 2023	11,627,108	$	2.41	5.29	$	511
Exercisable as of June 30, 2023	8,218,162	$	3.23	4.31	$	372

Schedule of RSU Activity

The following table summarizes the Company’s RSU award activity:

	Number of Shares	Weighted Average Grant Date Fair Value ($)
Unvested as of December 31, 2022	11,451,776	$	4.37
Granted	8,630,896	0.29
Vested	(2,089,190)	4.83
Forfeited	(1,945,396)	3.09
Unvested as of June 30, 2023	16,048,086	$	2.23